Pharmacodynamic study of Morphine and Tapentadol in Palliative Oncology
Not Applicable
- Conditions
- Health Condition 1: G319- Degenerative disease of nervous system, unspecified
- Registration Number
- CTRI/2020/01/023083
- Lead Sponsor
- Manipal Academy of Higher Education
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients above 18 years of age visiting the palliative care department having the prescription of Morphine in either of the dosage form or oral Tapentadol for pain management with the diagnosis of cancer of any type.
Exclusion Criteria
Incomplete case records, Patients who missed a follow-up
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method